Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: Evaluation in comparison with mesothelin - Lung Cancer
Soluble markers for diagnosis of malignant pleural mesothelioma | Biomarkers in Medicine
Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis | European Respiratory Society
Quantitative mass spectrometry to identify protein markers for diagnosis of malignant pleural mesothelioma - ScienceDirect
Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions - eBioMedicine
Malignant Mesothelioma Marker Selection - Mesothelioma in Focus
Genetics of malignant pleural mesothelioma: molecular markers and biologic targets - Thoracic Surgery Clinics
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - van Zandwijk - Journal of Thoracic Disease
Circulating biomarkers in malignant pleural mesothelioma
CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma | Scientific Reports
Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma - JTO Clinical and Research Reports
Pleural mesothelioma classification—update and challenges | Modern Pathology
Diagnostic Value of CYFRA 21–1 Tumor Marker and CEA in Pleural Effusion Due to Mesothelioma - CHEST
Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
Frontiers | Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
Markers for the non-invasive diagnosis of mesothelioma: a systematic review | British Journal of Cancer
Immunohistochemical markers used for malignant mesothelioma diagnosis... | Download Table
Malignant mesothelioma: A histomorphological and immunohistochemical study of 24 cases from a tertiary care hospital in Southern India Hui M, Uppin SG, Bhaskar K, Kumar NN, Paramjyothi GK - Indian J Cancer
The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review | Semantic Scholar